Erratum to “Down-regulation of hTERT and Cyclin D1 transcription via PI3K/Akt and TGF-β pathways in MCF-7 cancer cells with PX-866 and Raloxifene” [Exp. Cell Res. 344 (2016) 95-102].

The publisher regrets that Table 1 was published incorrectly. The correct table appears below.

The publisher would like to apologise for any inconvenience caused.

Table 1.

Significant relative levels of mRNA, protein and phosphorylated protein following three days of treatment with Raloxifene and/or PX-866.

Micromolar treatment	TERT	p21	Cyc D1	Axin2	LIF	HB EGF	DEC1
Control	1.00	1.00	1.00	1.00	1.00	1.00	1.00
1.0 Raloxifene				0.328*	0.158*	0.338*
0.4 PX-866
Raloxifene+0.1 PX-866	0.396*		0.398*	0.260*	0.283*	0.370*
Raloxifene+0.4 PX-866	0.539*		0.336*
Raloxifene+0.8 PX-866		2.76*	0.356*				1.95*
Micromolar treatment	pMDM2 protein
Control	1.0
1.0 Raloxifene
0.4 PX-866	0.379*
Raloxifene +0.1 PX-866	0.395*
Raloxifene +0.4 PX-866	0.385*
Raloxifene +0.8 PX-866	0.353*

^*p<0.05.